There are nearly 70,000 new cancer diagnoses made annually in adolescents and young
adults (AYAs) in the United States. Historically, AYA patients with cancer, aged 15 to 39 …

Pediatric thyroid cancer is a rare disease with an excellent prognosis. Compared with adults,
epithelial-derived differentiated thyroid cancer (DTC), which includes papillary and follicular …

Cancer statistics for adolescents and young adults (AYAs)(aged 15‐39 years) are often
presented in aggregate, masking important heterogeneity. The authors analyzed population …

BACKGROUND With prior reports indicating a lack of progress in survival improvement in
older adolescents and young adults (AYAs) aged 15 to 39 years with cancer compared with …

Background: Overdiagnosis is the leading factor contributing to the rapid increase in thyroid
cancer incidence of the last decades. During this period, however, thyroid cancer incidence …

Context: BRAFV600E is considered a primary event, a negative prognostic marker, and a
site for pharmacological intervention in papillary thyroid carcinoma (PTC). We asked …

Over 14 000 patients aged 15–24 are estimated to be diagnosed with cancer in the
European Union (EU) each year. Teenagers and young adults (TYA) often fall down gaps …

Objective To determine the relationship between age and rate of lymph node metastasis,
nodal burden of disease, as well as rate of lateral neck disease in papillary thyroid cancer …

Survival of patients with acute myeloid leukemia (AML) is inversely associated with age, but
the impact of race on outcomes of adolescent and young adult (AYA; range, 18-39 years) …

Purpose: A need to examine survival trends of individual cancers in older adolescents and
young adults (AYAs) is prompted by overall survival trends that have indicated a lack of …